File list
This special page shows all uploaded files.
![]() |
Name | Thumbnail | Size | Description | Versions |
---|---|---|---|---|---|
10:03, 5 May 2006 | Signaling Pathway linkage 050506.jpg (file) | ![]() |
82 KB | Interactive Signaling Pathways and Linkages between different pathways. | 1 |
04:36, 9 May 2006 | Slide1.GIF (file) | Error creating thumbnail: File missing |
16 KB | Interactive Signaling Pathways for the alopecia: There are different signaling pathways interact either individually or in co-cordinate with other pathways leading to the alopecia. The most common of these are Wnt pathway, TGF-beta pathway, BMP pathway, M | 1 |
00:06, 10 May 2006 | Revised pathway map 1.gif (file) | Error creating thumbnail: /var/www/htdocs/dolcera.com/wiki/includes/limit.sh: line 101: 1575 Aborted /usr/bin/timeout $MW_WALL_CLOCK_LIMIT /bin/bash -c "$1" 3>&- Error code: 134 |
26 KB | Finasteride is well know compound for treatment of alopecia. Which inhibit the Type II 5-α-reductase activity. The figure shows the basic SAR for 4-azasteroids at 5- -reductase (published in a review by Kenny et al). In general, a ketone in the 3-positi | 1 |
00:08, 10 May 2006 | SAR map.gif (file) | Error creating thumbnail: /var/www/htdocs/dolcera.com/wiki/includes/limit.sh: line 101: 1578 Aborted /usr/bin/timeout $MW_WALL_CLOCK_LIMIT /bin/bash -c "$1" 3>&- Error code: 134 |
26 KB | Finasteride is well know compound for treatment of alopecia. Which inhibit the Type II 5-α-reductase activity. The figure shows the basic SAR for 4-azasteroids at 5- -reductase (published in a review by Kenny et al). In general, a ketone in the 3-positi | 1 |
00:13, 10 May 2006 | Inhibition by finasteride.jpg (file) | ![]() |
49 KB | Testosterone Pathway inhibition by Finasteride in alopecia: Finasteride inhibits inhibit the Type II 5-α-reductase. | 1 |
00:17, 10 May 2006 | Pyrazol1.JPG (file) | 4 KB | Pyrazole compound of patent number US6989385 | 1 | |
00:18, 10 May 2006 | Pyrazol2.JPG (file) | 5 KB | Pyrazol compound of patent number US7008948 | 1 | |
00:18, 10 May 2006 | Pyrazol3.JPG (file) | 6 KB | Pyrazol compound disclosed in patent nuber US6977262 | 1 | |
00:19, 10 May 2006 | Pyrazol4.JPG (file) | 4 KB | Pyrazol compound disclosed in patent number US6664247 | 1 | |
00:19, 10 May 2006 | Pyrazol5.JPG (file) | 5 KB | Pyrazol compound disclosed in patent number US2004224944 | 1 | |
00:34, 10 May 2006 | Pyrazol1.jpeg (file) | ![]() |
4 KB | 1 | |
00:34, 10 May 2006 | Pyrazol2.jpeg (file) | ![]() |
5 KB | 1 | |
00:35, 10 May 2006 | Pyrazol3.jpeg (file) | ![]() |
6 KB | 1 | |
00:35, 10 May 2006 | Pyrazol4.jpeg (file) | ![]() |
4 KB | 1 | |
00:36, 10 May 2006 | Pyrazol5.jpeg (file) | ![]() |
5 KB | 1 | |
00:37, 10 May 2006 | Inhibition by finasteride.jpeg (file) | ![]() |
49 KB | 1 | |
05:19, 10 May 2006 | 5-alpha-reductase inhibition.jpg (file) | ![]() |
51 KB | Inhibition of 5-alpha reductase | 1 |
05:20, 10 May 2006 | 5-alpha-reductase inhibition.jpeg (file) | ![]() |
51 KB | Inhibition of 5-alpha reductase | 1 |
06:28, 10 May 2006 | Other derivates.jpeg (file) | ![]() |
40 KB | Other derivatives used for the treatment of alopecia. | 1 |
03:51, 14 July 2006 | GSK3 phosphorylation.jpg (file) | ![]() |
18 KB | 1 | |
03:58, 14 July 2006 | Gsk3 1.jpg (file) | ![]() |
47 KB | 1 | |
03:58, 14 July 2006 | Gsk3 2.JPG (file) | 201 KB | 1 | ||
03:59, 14 July 2006 | Gsk3 2.jpg (file) | ![]() |
201 KB | 1 | |
04:04, 14 July 2006 | Gsk-3 sequence.jpg (file) | ![]() |
47 KB | 1 | |
04:09, 14 July 2006 | Predication-gsk3.jpg (file) | ![]() |
85 KB | 1 | |
04:11, 14 July 2006 | Predication-gsk3-2.jpg (file) | ![]() |
69 KB | 1 | |
04:18, 14 July 2006 | Ways to inhibit gsk3.jpg (file) | ![]() |
24 KB | 1 | |
04:25, 14 July 2006 | Catenin.jpg (file) | ![]() |
5 KB | 1 | |
04:44, 14 July 2006 | In action.jpg (file) | ![]() |
27 KB | 1 | |
05:01, 14 July 2006 | Serine-pyrazol.jpg (file) | ![]() |
10 KB | 2 | |
03:53, 29 July 2006 | Mind-map.jpg (file) | ![]() |
727 KB | 1 | |
04:32, 29 July 2006 | Vasodiator.jpg (file) | ![]() |
200 KB | 1 | |
21:34, 29 July 2006 | Vasodiator2.jpg (file) | ![]() |
48 KB | 1 | |
21:00, 30 July 2006 | Vasodiator-rev.jpg (file) | ![]() |
90 KB | 1 | |
03:39, 15 September 2006 | IP activity.jpeg (file) | ![]() |
38 KB | 1 | |
03:40, 15 September 2006 | Assignees Involved – First cut.jpeg (file) | ![]() |
42 KB | 1 | |
05:13, 3 January 2007 | Savings rate trend.jpg (file) | ![]() |
38 KB | 1 | |
05:13, 3 January 2007 | Household savings distribution.jpg (file) | ![]() |
25 KB | 1 | |
05:16, 3 January 2007 | Savings trend rate.jpg (file) | ![]() |
38 KB | 1 | |
05:16, 3 January 2007 | Household income distribution.jpg (file) | ![]() |
25 KB | 1 | |
23:19, 3 January 2007 | Payments to 3rd parties using ATM's.jpg (file) | ![]() |
121 KB | 1 | |
00:06, 4 January 2007 | Diabetes - first draft.ppt (file) | ![]() |
1.37 MB | 1 | |
00:11, 4 January 2007 | Substitutes for High fructose corn syrup.jpeg (file) | ![]() |
39 KB | 1 | |
00:12, 4 January 2007 | Key ingredient of Oreo cookies.jpeg (file) | ![]() |
35 KB | 1 |
![]() First page |
![]() Previous page |
![]() Next page |
![]() Last page |